SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-21-022977
Filing Date
2021-11-12
Accepted
2021-11-12 08:05:39
Documents
15
Period of Report
2021-11-12
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ardx-20211112.htm   iXBRL 8-K 33910
2 EX-99.1 ardx-20210930xexhibit991.htm EX-99.1 71905
6 ardx-20211112_g1.jpg GRAPHIC 2570
7 image_0.jpg GRAPHIC 2381
  Complete submission text file 0001628280-21-022977.txt   263623

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ardx-20211112.xsd EX-101.SCH 1899
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ardx-20211112_lab.xml EX-101.LAB 24849
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ardx-20211112_pre.xml EX-101.PRE 13044
8 EXTRACTED XBRL INSTANCE DOCUMENT ardx-20211112_htm.xml XML 11173
Mailing Address 34175 ARDENWOOD BLVD. FREMONT CA 94555
Business Address 34175 ARDENWOOD BLVD. FREMONT CA 94555 510-745-7047
ARDELYX, INC. (Filer) CIK: 0001437402 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36485 | Film No.: 211399751
SIC: 2834 Pharmaceutical Preparations